Interpace Biosciences Inc.

10/15/2024 | Press release | Distributed by Public on 10/15/2024 14:16

Interpace Biosciences Announces Capital Restructuring of Its Preferred Stock as a First Step Toward Seeking an Uplisting of Its Common Stock to Nasdaq

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.